Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
07/2003
07/03/2003WO2003053224A2 Novel compositions and methods for cancer
07/03/2003WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003WO2003053136A2 Triple transgenic mouse model of alzheimer's disease
07/03/2003WO2003030823A3 Combinations for the treatment of immunoinflammatory disorders
07/03/2003WO2003013476B1 Compositions and methods to prevent abuse of opioids
07/03/2003WO2003013437A3 Compositions and methods for the prevention and treatment of huntington's disease
07/03/2003WO2002101009A3 Structural and cytoskeleton-associated proteins
07/03/2003WO2002092014A3 Destruction of prions using vibriolysin or variants thereof
07/03/2003WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles
07/03/2003WO2002079189A3 Spiroisoquinoline compounds, methods for their preparation and intermediates
07/03/2003WO2002076497A3 Method and composition
07/03/2003WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto
07/03/2003WO2002059604A3 Diagnosis and treatment of multiple sclerosis
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002028481A9 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies
07/03/2003WO2002024754A8 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative
07/03/2003WO2002022801A9 Mammalian receptor genes and uses
07/03/2003WO2002020049A3 Eiav chimeric vaccine and diagnostic
07/03/2003WO2002016340A8 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
07/03/2003US20030125659 Dosage of transdermal delivery systems
07/03/2003US20030125568 Defects in the crystal lattice are detectable by X-ray analysis, e.g. by smaller line spacings with otherwise predominantly identical lines or bands; antiepileptic agent
07/03/2003US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder
07/03/2003US20030125559 Methods for synthesizing ether compounds and intermediates therefor
07/03/2003US20030125533 Regulation of human sphingosine kinase-like protein
07/03/2003US20030125519 Ligand for the c-kit receptor and methods of use thereof
07/03/2003US20030125391 Pharmaceutical solutions of modafinil compounds
07/03/2003US20030125385 Prepared by mixing gamma-hydroxybutyrate and a pH-adjusting agent in an aqueous medium
07/03/2003US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor
07/03/2003US20030125365 Inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease
07/03/2003US20030125363 Riluzole and alpha-tocopherol combination
07/03/2003US20030125361 1H-benzo(g)indazole compounds as anticarcinogenic agents and also treat arthritis
07/03/2003US20030125360 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases
07/03/2003US20030125354 Aromatic compounds containing urea or thiourea groups are useful for terating cytokine mediated diseases
07/03/2003US20030125353 Method of treatment
07/03/2003US20030125347 An oral dosage form containing an opiate and a capsaicinoid irritant, opiate is selected from codeine, hydrocodone, hydromorphone, levorphanol, meperidine, morphine, oxycodone and their salts for the traeatment of drug abuse
07/03/2003US20030125345 Nicotinic compounds; treating central nervous system disorders
07/03/2003US20030125344 Rho-kinase inhibitors
07/03/2003US20030125342 6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
07/03/2003US20030125338 Compounds, compositions and methods for modulating beta-amyloid production
07/03/2003US20030125334 5-HT receptor ligands and uses thereof
07/03/2003US20030125333 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
07/03/2003US20030125332 Pyrazolo(3,4-c)pyridazin-3-ylamine derivatives; glycogen synthase kinase-3 (gsk-3); treatment and prevention of diabetes and Alzheimer's disease
07/03/2003US20030125330 Anxiolytics and antidepressants
07/03/2003US20030125324 Alpha 4 beta 1 integrin and CD49d/ CD29 (vla-4); antiinflammatory agents
07/03/2003US20030125322 Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno [2,3-b][1,5]benzodiazepine
07/03/2003US20030125320 Seratonin reuptake inhibitors potently binding to the 5-HT1A receptor, dopaminergic agents; antidepressants, psychosis, anxiolytic and antiischemic agents; panic order; obsessive compulsive disorder, impulse control disorder, alcohol abuse
07/03/2003US20030125318 Benzothiazole derivatives with activity as adenosine receptor ligands
07/03/2003US20030125257 A olilgopeptide or polypeptide containing Leustatin, Chastatin or Tyrstatin
07/03/2003US20030125247 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein
07/03/2003US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment
07/03/2003US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents
07/03/2003US20030124649 Membrane associated proteins
07/03/2003US20030124617 Antiinflammatory agents; antiarthritic agents; interleukins; antiallergens; bronchodilator agents
07/03/2003US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor
07/03/2003US20030124534 Measuring expression of nucleotide sequences in cells
07/03/2003US20030124201 Administering isotopically pure heavy water, carbonate or phosphate either containing deuterium and no hydrogen or hydrogen and no deuterium
07/03/2003US20030124193 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale.
07/03/2003US20030124190 Methods and compositions for treating pain of the mucous membrane
07/03/2003US20030124188 Oral pulsed dose drug delivery system
07/03/2003US20030124184 Liquiflash particles and an excipient mass; friability of less than 1%; need for conventional super disintegrant and having a friability of less than 1%; no need for conventional superdisintegrant
07/03/2003US20030124150 Kit for reducing aching
07/03/2003US20030124123 Also an IL-12 anti-idiotype antibody to the antibody
07/03/2003US20030124107 PAK5-related compositions and methods
07/03/2003US20030124095 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex
07/03/2003US20030124086 Polymer conjugates of opioid antagonists
07/03/2003CA2849201A1 Adipose-derived cell processing unit
07/03/2003CA2471461A1 Pyrrolidine-2-ones as factor xa inhibitors
07/03/2003CA2471263A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471120A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same
07/03/2003CA2471107A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators
07/03/2003CA2471087A1 Pyrazolyl-substituted triazoloquinoxalines
07/03/2003CA2471085A1 Aroyl pyridinones
07/03/2003CA2471083A1 Benzhydryl derivatives
07/03/2003CA2471081A1 Formulation & dosage form for the controlled delivery of therapeutic agents
07/03/2003CA2471057A1 Benzothia(dia)zine derivatives and their use as ampa modulators
07/03/2003CA2470900A1 Compositions and methods for the diagnosis and treatment of tumor
07/03/2003CA2470856A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines
07/03/2003CA2470844A1 Novel compositions and methods for cancer
07/03/2003CA2470808A1 Piperazine derivative
07/03/2003CA2470612A1 Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
07/03/2003CA2470603A1 Methods for the treatment of peripheral neural and vascular ailments
07/03/2003CA2470594A1 Leptin proteins
07/03/2003CA2470576A1 Methods for slowing senescence and treating and preventing diseases associated with senescence
07/03/2003CA2470443A1 Pharmaceutical compositions based on azetidine derivatives
07/03/2003CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration
07/03/2003CA2469884A1 7-amino-benzothiazole derivatives as adenosine receptor ligands
07/03/2003CA2469872A1 Benzothiophenes as adenosine receptor modulators
07/03/2003CA2469658A1 Adeno-associated virus-mediated delivery of gdnf to skeletal muscles
07/03/2003CA2469370A1 Adipose-derived cell processing unit
07/03/2003CA2469278A1 Isochroman compounds for treatment of cns disorders
07/03/2003CA2469047A1 Tempamine compositions and methods of use
07/03/2003CA2468972A1 Methods of treating psychosis and schizophrenia based on a polymorphism in the ctf gene
07/03/2003CA2468083A1 Use of heterocyclic carboxamides to treat anemia
07/03/2003CA2467118A1 Aryloxyphenyl and arylsulfanylphenyl derivatives
07/03/2003CA2466928A1 Treatment of neurodegenerative and cardiovascular disorders
07/03/2003CA2448811A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases
07/02/2003EP1323716A1 Promoters for the proliferation and differentiation of stem cells and/or neuron precursor cells
07/02/2003EP1323714A1 1,3-selenazole derivatives and their use as anticancer drugs or as agrochemicals
07/02/2003EP1323713A1 5-phenylbenzylamine compounds, process for their production and intermediates for their synthesis
07/02/2003EP1323712A1 Process for producing multiform crystal of donepezil hydrochloride
1 ... 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 ... 1833